Phospho-CTTN (Y421) Antibody

What is the biological significance of cortactin phosphorylation at Y421?

Cortactin phosphorylation at tyrosine 421 represents a critical regulatory mechanism that influences multiple cellular functions. This post-translational modification contributes to the organization of the actin cytoskeleton and determination of cell shape, which are fundamental processes in cellular biology . Furthermore, phosphorylation at Y421 plays essential roles in the formation of lamellipodia and subsequent cell migration. In neuronal contexts, this phosphorylation event regulates neuron morphology, axon growth, and the formation of neuronal growth cones . The Y421 phosphorylation also influences cortactin's ability to participate in focal adhesion assembly and turnover, which is crucial for cell adhesion and motility. Particularly concerning in pathological contexts, phosphorylation at this site has been implicated in enhancing the invasiveness of cancer cells and promoting metastasis formation . The multifaceted impact of this single phosphorylation event illustrates the complexity of cellular signaling networks and the importance of studying specific post-translational modifications.

How does Src kinase specifically target Y421 in cortactin?

Src kinase exhibits specific targeting of tyrosine 421 in cortactin through a precise molecular recognition mechanism. Research utilizing the FIT (Fluorescence Imaging Technique) system has demonstrated that Src kinase predominantly phosphorylates three tyrosine residues in mouse cortactin: Y421, Y466, and Y482 . The specificity of this targeting was confirmed through experiments with a non-phosphorylatable mutant (3F) in which these three tyrosine residues were replaced with phenylalanine. When cells were co-transfected with Src kinase and either wild-type cortactin or the 3F mutant, only the wild-type cortactin showed tyrosine phosphorylation . This indicates that Src kinase specifically recognizes and phosphorylates these residues without significant off-target phosphorylation of other tyrosines in cortactin. The molecular basis for this specificity likely involves recognition of the surrounding amino acid sequence context, as well as potential conformational requirements that position these tyrosine residues optimally within the Src kinase active site.

What is the relationship between cortactin phosphorylation and acetylation?

The relationship between cortactin phosphorylation and acetylation represents a complex regulatory interplay that appears to be mutually exclusive. Research utilizing immunoprecipitation techniques has revealed that cortactin molecules phosphorylated at Y466 do not simultaneously carry acetyl modifications . This reciprocal relationship was demonstrated by immunoprecipitation experiments using acetyl-cortactin antibodies, which showed that phosphorylated cortactin was not present in these immunoprecipitates . Additionally, studies in HDAC6-deficient cells further illuminate this relationship. HDAC6 (Histone Deacetylase 6) is responsible for deacetylating cortactin, and in HDAC6-deficient cells, the ratio of acetylated to phosphorylated cortactin is significantly altered compared to wild-type cells . This suggests that acetylation and phosphorylation may function as a molecular switch mechanism, whereby one modification precludes the other, potentially directing cortactin toward distinct functional outcomes. The molecular basis for this mutual exclusivity may involve conformational changes induced by one modification that prevents enzyme access for the other modification.

What are the optimal conditions for using Phospho-CTTN (Y421) antibodies in Western blotting?

Optimal conditions for Western blotting with Phospho-CTTN (Y421) antibodies require careful attention to several methodological parameters to ensure specific detection and quantifiable results. Based on published protocols, researchers should load approximately 5-30 μg of total protein per lane, as this range has been demonstrated to provide detectable signals without saturation . For antibody dilution, a 1:500 ratio has been successfully employed in previous studies, though optimization may be necessary for different experimental systems . Regarding sample preparation, it's crucial to maintain phosphorylation status by including phosphatase inhibitors in lysis buffers. Some researchers have employed hydrogen peroxide treatment (150 μM H₂O₂) to enhance phosphorylation signals, which serves as a useful positive control . When detecting both total and phosphorylated cortactin, a dual-color detection system like Odyssey scanning is recommended, as it allows simultaneous visualization of both signals without stripping and reprobing . For accurate interpretation, researchers should expect phosphorylated cortactin to display slightly reduced electrophoretic mobility compared to unphosphorylated cortactin, appearing as a band at approximately 80-85 kDa . Including appropriate controls, such as phosphatase-treated samples or cells expressing non-phosphorylatable cortactin mutants (Y421F), is essential for validating signal specificity.

How can I design experiments to study the dynamics of Y421 phosphorylation in live cells?

Designing experiments to study the dynamics of Y421 phosphorylation in live cells requires sophisticated approaches that capture real-time molecular events. A recommended approach is to adapt the Fluorescence Imaging Technique (FIT) system, which has been successfully employed to study cortactin phosphorylation . This system involves co-expressing two fusion proteins: the kinase of interest (such as Src lacking SH2 and SH3 domains) fused to one leucine zipper domain, and cortactin fused to a complementary leucine zipper domain . To monitor phosphorylation dynamics, researchers can incorporate fluorescent protein tags or phospho-specific biosensors that undergo conformational changes upon phosphorylation, resulting in FRET (Förster Resonance Energy Transfer) signal alterations. Time-lapse imaging following stimulation with growth factors or other activators of Src kinase can reveal the spatiotemporal patterns of Y421 phosphorylation. For improved spatial resolution, techniques such as TIRF (Total Internal Reflection Fluorescence) microscopy are advantageous, particularly when examining cortactin phosphorylation at cell protrusions or focal adhesions. To validate that observed signals genuinely represent Y421 phosphorylation, parallel experiments should include cortactin constructs with Y421F mutations as negative controls . Additionally, pharmacological inhibitors of Src kinase can be introduced during imaging to confirm signal specificity and observe dephosphorylation dynamics.

What methodological approaches can distinguish between phosphorylation at Y421, Y466, and Y482?

Distinguishing between phosphorylation at Y421, Y466, and Y482 in cortactin requires methodologies with high specificity for individual phosphorylation sites. The most direct approach involves using site-specific phospho-antibodies that recognize only one phosphorylated residue, such as anti-pY421 or anti-pY466 antibodies . Western blotting with these antibodies allows for separate detection of each phosphorylation event. For more quantitative analysis, researchers can employ mass spectrometry-based approaches, particularly multiple reaction monitoring (MRM) or parallel reaction monitoring (PRM), which can precisely quantify phosphopeptides containing each of these sites. Mutational analysis provides another valuable methodology, where cortactin constructs with specific tyrosine-to-phenylalanine mutations (Y421F, Y466F, Y482F, or combinations) can be expressed in cells . Comparing phosphorylation patterns between wild-type and mutant proteins helps delineate the contribution of each site. To understand site-specific functions, researchers can design rescue experiments in cortactin-depleted backgrounds, expressing either wild-type cortactin or single-site phospho-mutants, then measuring functional outcomes such as cell migration or invadopodia formation. The FIT system can be particularly valuable when combined with specific mutants, as it allows controlled phosphorylation and direct comparison of outcomes when only one site is available for modification .

How can I determine if Y421 phosphorylation affects specific protein-protein interactions of cortactin?

Determining whether Y421 phosphorylation affects specific protein-protein interactions of cortactin requires methodical approaches that directly compare interaction profiles in different phosphorylation states. Co-immunoprecipitation experiments represent a foundational approach, wherein cortactin is immunoprecipitated from cells under conditions promoting or inhibiting Y421 phosphorylation (such as Src activation or inhibition), followed by immunoblotting for potential binding partners . For controlled comparison, the FIT system can be employed to generate specifically phosphorylated cortactin, using either wild-type cortactin or Y421F mutants as controls, and then analyzing differential binding partners . To identify novel interactions affected by Y421 phosphorylation, researchers can utilize phospho-mimetic (Y421E or Y421D) and non-phosphorylatable (Y421F) mutations in pull-down assays coupled with mass spectrometry. These phospho-mimetics, while imperfect, can provide valuable insights when carefully validated against actual phosphorylation. Microscopy-based approaches such as proximity ligation assays (PLA) or FRET can visualize interactions in situ, revealing whether phosphorylation affects not only binding affinity but also subcellular localization of interactions. For direct biophysical measurements, surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) can quantitatively compare binding affinities of purified interaction partners with phosphorylated, phospho-mimetic, or non-phosphorylated cortactin. When analyzing data from these experiments, researchers should pay particular attention to interactions with known cortactin partners such as CTTNBP2, ABL1, and MYLK, which have established functional relationships with cortactin in various cellular processes .

How does phosphorylation at Y421 influence cortactin's role in cancer cell invasion and metastasis?

Phosphorylation at Y421 significantly enhances cortactin's capability to promote cancer cell invasion and metastasis through multiple molecular mechanisms. Research has demonstrated that Y421 phosphorylation directly contributes to the invasiveness of cancer cells and the formation of metastases . This phosphorylation event modifies cortactin's functional interactions with the actin cytoskeleton, particularly affecting its ability to regulate the formation and stability of invadopodia—specialized actin-rich membrane protrusions that facilitate extracellular matrix degradation during invasion. At the molecular level, Y421 phosphorylation creates binding sites for SH2 domain-containing proteins, which assemble signaling complexes that promote matrix metalloproteinase secretion and activation at invadopodia. The phosphorylation also enhances cortactin's ability to activate the Arp2/3 complex, increasing actin polymerization at the leading edge of invasive structures. To quantitatively assess this relationship, researchers have employed various experimental models including:

These findings underscore the critical role of site-specific phosphorylation in pathological cell behavior and highlight potential therapeutic opportunities targeting this modification or its downstream effects.

What is the interplay between HDAC6-mediated deacetylation and Y421 phosphorylation of cortactin?

The interplay between HDAC6-mediated deacetylation and Y421 phosphorylation represents a sophisticated regulatory mechanism controlling cortactin function. Experimental evidence demonstrates a mutually exclusive relationship between these two post-translational modifications. Immunoprecipitation studies have revealed that acetylated cortactin is not simultaneously phosphorylated at Y421 or Y466, suggesting these modifications occur on distinct subpopulations of cortactin molecules . Analysis of HDAC6-deficient cells provides compelling evidence for this regulatory relationship: in the absence of HDAC6, cortactin remains hyperacetylated, and consequently, Y421 phosphorylation levels are significantly reduced . The quantitative analysis of immunoprecipitated cortactin from wild-type and HDAC6-deficient cells reveals a dramatic shift in the acetyl:phospho ratio, as illustrated below:

This approximately 4.5-fold increase in the acetyl:phospho ratio indicates that HDAC6 activity is a prerequisite for efficient Y421 phosphorylation . Mechanistically, acetylation likely induces conformational changes in cortactin that render Y421 inaccessible to kinases like Src. Alternatively, acetylation may recruit proteins that sterically hinder kinase access or promote phosphatase recruitment. This regulatory switch has significant functional consequences, as phosphorylation and acetylation direct cortactin toward distinct cellular processes—phosphorylation promoting cell migration and invasion, while acetylation stabilizes actin networks. This interplay provides cells with a mechanism to rapidly switch cortactin function between different cytoskeletal activities.

How can phospho-specific antibodies be used to investigate the spatial regulation of cortactin phosphorylation during cell migration?

Phospho-specific antibodies against cortactin Y421 serve as powerful tools for investigating the spatial regulation of cortactin phosphorylation during cell migration when implemented in sophisticated imaging protocols. Immunofluorescence microscopy with anti-phospho-Y421 antibodies allows visualization of phosphorylated cortactin at specific subcellular locations, particularly at the leading edge of migrating cells where lamellipodia formation occurs . For optimal results, researchers should perform dual staining with both phospho-Y421 and total cortactin antibodies raised in different species, enabling ratiometric analysis that controls for variations in cortactin concentration throughout the cell. Super-resolution microscopy techniques such as STORM or PALM can further enhance spatial resolution, allowing researchers to precisely map phosphorylated cortactin relative to other cytoskeletal components like F-actin, Arp2/3 complex, or focal adhesion proteins. To investigate dynamic regulation during migration, researchers can implement live-cell imaging using FRET-based biosensors that contain both cortactin and a phospho-Y421-specific binding domain, producing conformational changes and FRET signal alterations upon phosphorylation. Combining these approaches with microfluidic devices that establish chemotactic gradients allows investigation of how directional cues spatially regulate cortactin phosphorylation. For quantitative spatial analysis, researchers should employ computational image analysis tools that measure phosphorylation intensity as a function of distance from the cell edge or relative to structures like focal adhesions. To validate the specificity of phospho-antibody staining, essential controls include Y421F mutant-expressing cells, Src inhibitor treatments, and phosphatase-treated fixed samples, all of which should show reduced or eliminated phospho-specific staining .

How can I verify the specificity of my phospho-Y421 antibody signal?

Verifying the specificity of phospho-Y421 antibody signals requires multiple complementary approaches to eliminate false positives and ensure reliable data interpretation. The gold standard control involves parallel analysis of cells expressing wild-type cortactin versus those expressing Y421F mutant cortactin, where the latter should show substantially reduced or absent signal with the phospho-specific antibody . Additionally, researchers should perform phosphatase treatment controls, wherein cell lysates are incubated with lambda phosphatase prior to immunoblotting, which should eliminate phospho-Y421 signal while preserving total cortactin detection. Pharmacological inhibition of Src kinase (using inhibitors such as PP2 or saracatinib) should significantly reduce phospho-Y421 signal, providing further confirmation of specificity . For immunoprecipitation experiments, comparing the results from phospho-Y421 antibody to isotype control antibodies is essential to rule out non-specific binding . Peptide competition assays, where the antibody is pre-incubated with excess phospho-Y421 peptide before application to samples, should abolish specific signals. When conducting immunofluorescence microscopy, researchers should verify that phospho-Y421 staining colocalizes with total cortactin staining and exhibits the expected subcellular distribution at sites like lamellipodia or invadopodia. Additionally, the observation of reduced electrophoretic mobility for the phosphorylated band compared to total cortactin provides supporting evidence for correct target identification . Implementing multiple validation approaches from this comprehensive list creates a robust framework for confirming phospho-Y421 antibody specificity.

How can I develop a quantitative assay to measure absolute levels of Y421 phosphorylation in cell and tissue samples?

Developing a quantitative assay for absolute measurement of Y421 phosphorylation requires sophisticated analytical approaches that provide precise stoichiometric information. Mass spectrometry-based methods represent the gold standard for absolute quantification, particularly selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) approaches. These techniques involve digesting protein samples with trypsin, then monitoring specific transitions corresponding to phosphorylated and non-phosphorylated peptides containing Y421. For absolute quantification, synthetic isotope-labeled peptides representing both phosphorylated and non-phosphorylated forms serve as internal standards. The ratio of endogenous to labeled peptide signals allows calculation of absolute quantities, while the ratio of phosphorylated to total peptide provides phosphorylation stoichiometry. The table below outlines recommended mass transitions for monitoring cortactin Y421 phosphorylation:

For higher throughput analysis suitable for multiple samples, a quantitative ELISA can be developed using a capture antibody against total cortactin and detection with phospho-Y421-specific antibody . This approach requires careful standardization using purified cortactin protein with defined phosphorylation states. To generate such standards, in vitro kinase reactions with purified Src and cortactin can produce fully phosphorylated protein, while phosphatase-treated cortactin provides a non-phosphorylated standard . Mixing these standards in defined ratios creates a calibration curve relating signal to absolute phosphorylation percentage. For tissue samples, where matrix effects may complicate analysis, phospho-specific Western blotting remains valuable but should be enhanced with phosphopeptide enrichment steps prior to analysis and inclusion of spiked-in standards for normalization.